You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Mallinckrodt
Moodys
Medtronic
AstraZeneca

Last Updated: January 28, 2021

DrugPatentWatch Database Preview

CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Chlordiazepoxide Hydrochloride And Clidinium Bromide patents expire, and when can generic versions of Chlordiazepoxide Hydrochloride And Clidinium Bromide launch?

Chlordiazepoxide Hydrochloride And Clidinium Bromide is a drug marketed by Eci Pharms Llc, Misemer, and Nuvo Pharms Inc. and is included in three NDAs.

The generic ingredient in CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE is chlordiazepoxide hydrochloride; clidinium bromide. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride; clidinium bromide profile page.

Summary for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
Drug patent expirations by year for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
Pharmacology for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

US Patents and Regulatory Information for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eci Pharms Llc CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE chlordiazepoxide hydrochloride; clidinium bromide CAPSULE;ORAL 213530-001 Oct 20, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
Misemer CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE chlordiazepoxide hydrochloride; clidinium bromide CAPSULE;ORAL 210579-001 Jul 29, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
Nuvo Pharms Inc CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE chlordiazepoxide hydrochloride; clidinium bromide CAPSULE;ORAL 211421-001 Jul 7, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Colorcon
AstraZeneca
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.